Literature DB >> 26190848

Developing Federal Clinical Care Recommendations for Women.

Emily M Godfrey1, Naomi K Tepper1, Kathryn M Curtis1, Susan B Moskosky2, Loretta E Gavin3.   

Abstract

UNLABELLED: The provision of family planning services has important health benefits for the U.S. POPULATION: Approximately 25 million women in the U.S. receive contraceptive services annually and 44 million make at least one family planning-related clinical visit each year. These services are provided by private clinicians, as well as publicly funded clinics, including specialty family planning clinics, health departments, Planned Parenthoods, community health centers, and primary care clinics. Recommendations for providing quality family planning services have been published by CDC and the Office of Population Affairs of the DHHS. This paper describes the process used to develop the women's clinical services portion of the new recommendations and the rationale underpinning them. The recommendations define family planning services as contraceptive care, pregnancy testing and counseling, achieving pregnancy, basic infertility care, sexually transmitted disease services, and preconception health. Because many women who seek family planning services have no other source of care, the recommendations also include additional screening services related to women's health, such as cervical cancer screening. These clinical guidelines are aimed at providing the highest-quality care and are designed to establish a national standard for family planning in the U.S. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26190848     DOI: 10.1016/j.amepre.2015.02.023

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  1 in total

1.  Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age - United States, 2011-2013.

Authors:  Karen Pazol; Cheryl L Robbins; Lindsey I Black; Katherine A Ahrens; Kimberly Daniels; Anjani Chandra; Anjel Vahratian; Lorrie E Gavin
Journal:  MMWR Surveill Summ       Date:  2017-10-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.